Edges in Network
| Network | GSE5851_egf1520 - GSE5851 - SiGN-BN HC+Bootstrap |
| Network Description | Phase II exploratory pharmacogenomics study of cetuximab monotherapy in patients with advanced metastatic CRC |
| Node | NOS3 |
| Upstream (Parents) |
|---|
| (<<) ALOX15B → NOS3 |
| (<<) BCL2A1 → NOS3 |
| (<<) CDK6 → NOS3 |
| (<<) FDPS → NOS3 |
| (<<) ILK → NOS3 |
| (<<) JUNB → NOS3 |
| (<<) MYLK → NOS3 |
| (<<) PROCR → NOS3 |
| (<<) RAD51L3 → NOS3 |
| (<<) SGK1 → NOS3 |
| (<<) TNFAIP3 → NOS3 |
| Downstream (Children) |
|---|
| NOS3 → APC2 (>>) |
| NOS3 → CAMKK2 (>>) |
| NOS3 → KLK3 (>>) |
| NOS3 → KRT5 (>>) |
| NOS3 → NRN1 (>>) |
| NOS3 → PKIA (>>) |
| NOS3 → RAB5C (>>) |
| NOS3 → SMAD3 (>>) |
| NOS3 → SOCS1 (>>) |
